Nitric oxide synthase inhibition reduces the O2 cost of force development in rat hindlimb muscles pump perfused at matched convective O 2 delivery

Experimental Physiology

Volumn 90, Issue 6, 2005, Pages 889-900

  Krause, Daniel J ^a   Hagen, Jason L ^a   Kindig, Casey A ^b   Hepple, Russell T ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; LACTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXYGEN;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HINDLIMB; LACTATE BLOOD LEVEL; MALE; METABOLIC ACTIVATION; MUSCLE ACTION POTENTIAL; MUSCLE BLOOD FLOW; MUSCLE CONTRACTILITY; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE PERFUSION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; RAT;

EID: 27844494319     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2005.031567     Document Type: Article

References (33)

1. Albertini M, Lafortuna C & Aguggini G (1997). Effects of nitric oxide on diaphragmatic muscle endurance and strength in pigs. Exp Physiol 82, 99-106.
2. Ameredes BT & Provenzano MA (1999). Influence of nitric oxide on vascular resistance and muscle mechanics during tetanic contractions in situ. J Appl Physiol 87, 142-151.
3. Brown GC (1995). Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369, 136-139.
4. de Wit C, Jahrbeck B, Shafer C, Bolz S & Pohl U (1997). Nitric oxide opposes myogenic pressure responses predominantly in large arterioles in vivo. Hypertension 31, 787-794.
5. Endo T, Imaizumi T, Tagawa T, Shiramoto M, Ando S & Takeshita A (1994). Role of nitric oxide in exercise-induced vasodilation of the forearm. Circulation 90, 2886-2890.
6. G-nitro-L-arginine methyl ester in humans. J Physiol 531, 257-264.
7. Giulivi C (1998). Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem J 332, 673-679.
8. Glantz SA (2002). Primer of Biostatistics, 5th edn. McGraw-Hill, New York.
9. Gorski J, Hood DA & Terjung RL (1986). Blood flow distribution in tissues of perfused rat hindlimb preparations. Am J Physiol 250, E441-E448.
10. 2 uptake in rat skeletal muscles in situ. J Physiol 541, 1003-1012.
11. Hepple RT, Krause DJ, Hagen JL & Jackson CC (2003). V̇O2 max is unaffected by altering the temporal pattern of stimulation frequency in rat hindlimb in situ. J Appl Physiol 95, 705-711.
12. Hillig T, Krustrup P, Fleming I, Osada T, Saltin B & Hellsten Y (2003). Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans. J Physiol 546, 307-314.
13. Hood DA, Gorski J & Terjung RL (1986). Oxygen cost of twitch and tetanic isometric contractions of rat skeletal muscle. Am J Physiol 250, E449-E456.
14. Ishizaka H, Okumura K, Yamabe H, Tsuchiya T & Yasue H (1991). Endothelium-derived nitric oxide as a mediator of acetylcholine-induced coronary vasodilation in dogs. J Cardiovasc Pharmacol 18, 665-669.
15. O2 kinetics in the transition to moderate-intensity exercise in man. J Physiol 552, 265-272.
16. Juncos L, Garvin J, Carretero O & Ito S (1995). Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. J Clin Invest 95, 2741-2748.
17. Kindig C, McDonough P, Erickson H & Poole D (2001). Effect of L-NAME on oxygen uptake kinetics during heavy-intensity exercise in the horse. J Appl Physiol 91, 891-896.
18. Kindig C, McDonough P, Erickson H & Poole D (2002). Nitric oxide synthase inhibition speeds oxygen uptake kinetics in horses during moderate domain running. Respir Physiol Neurobiol 132, 169.
19. King-VanVlack CE, Curtis SE, Mewburn JD, Cain SM & Chapler CK (1995). Role of endothelial factors in active hyperemic responses in contracting canine muscle. J Appl Physiol 79, 107-112.
20. King-VanVlack CE, Mewburn JD, Chapler CK & MacDonald PH (2002). Endothelial modulation of skeletal muscle blood flow and V̇O2 during low- and high-intensity contractions. J Appl Physiol 92, 461-468.
21. Kobzik L, Reid MB, Bredt DS & Stamler JS (1994). Nitric oxide in skeletal muscle. Nature 372, 546-548.
22. Laughlin M & Armstrong R (1982). Rat muscle blood flows during high-speed locomotion. J Appl Physiol 59, 1322-1328.
23. Li JM, Fenton RA, Cutler BS & Dobson JG Jr (1995). Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol 269, C519-C523.
24. McAllister RM & Terjung RL (1990). Acute inhibition of respiratory capacity of muscle reduces peak oxygen consumption. Am J Physiol 259, C889-C896.
25. Morrison RJ, Miller CC III & Reid MB (1996). Nitric oxide effects on shortening velocity and power production in the rat diaphragm. J Appl Physiol 80, 1065-1069.
26. Reading SA & Barclay JK (2001). Al receptor activation decreases fatigue in mammalian slow-twitch skeletal muscle in vitro. Can J Physiol Pharmacol 79, 496-501.
27. Reid MB (1998). Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand 162, 401-409.
28. Reid MB, Kobzik L, Bredt DS & Stamler JS (1998). Nitric oxide modulates excitation-contraction coupling in the diaphragm. Comparative Biochem Physiol 119A, 211-218.
29. Robinson DM, Ogilvie RW, Tullson PC & Terjung RL (1994). Increased peak oxygen consumption of trained muscle requires increased electron flux capacity. J Appl Physiol 77, 1941-1952.
30. Shen W, Xu X, Ochoa M, Zhao G, Bernstein RD, Forfia P & Hintze TH (2000). Endogenous nitric oxide in the control of skeletal muscle oxygen extraction during exercise. Acta Physiol Scand 168, 675-686.
31. Stamler JS & Meissner G (2001). Physiology of nitric oxide in skeletal muscle. Physiol Rev 81, 209-237.
32. Ward ME & Hussain SN (1994). Diaphragmatic pressure-flow relationship during hemorrhagic shock: role of nitric oxide. J Appl Physiol 77, 2244-2249.
33. 2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine. Hypertension 16, 162-169.